Relative Bioavailability of Dextromethorphan Syrup in Comparison to Dextromethorphan Soft Pastilles in Healthy Male and Female Subjects
NCT02191709 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2014-07-16
Summary
Study to investigate the relative bioavailability of orally administered dextromethorphan syrup in comparison to dextromethorphan (DMP) soft pastilles in healthy male and female subjects who are extensive metabolisers for CYP 2D6
Conditions
- Healthy
Interventions
- DRUG
-
Dextromethorphan syrup
- DRUG
-
Dextromethorphan soft pastilles
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2009-02-28
More Related Trials
-
Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate
NCT03642873 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates
NCT06632990 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults
NCT07213310 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects
NCT02704559 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers
NCT04019652 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Pharmacokinetic Study of RX0041-2
NCT02667106 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1
NCT03959189 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers
NCT02947139 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the PK of Ketorolac Tromethamine Intranasal and to Assess the Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine
NCT01363089 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Potential Pharmacokinetic Interactions Between Probe Drugs in the Geneva Phenotyping Cocktail
NCT02391688 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects
NCT05106205 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State
NCT05098262 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
NCT01573663 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State
NCT05098275 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Between R1_PBK_M2301 and R2_PBK_M2301 in Healthy Adults
NCT07017335 ·Status: COMPLETED ·Phase: PHASE1
-
Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
NCT00964106 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
NCT02227173 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response
NCT03694119 ·Status: COMPLETED ·Phase: PHASE1
-
Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension
NCT00853190 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition
NCT01606059 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers
NCT02952755 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers
NCT00931073 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
NCT07216313 ·Status: COMPLETED ·Phase: PHASE1
-
TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins.
NCT00866853 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine
NCT01358968 ·Status: COMPLETED ·Phase: PHASE1